EXSERVAN is a Oral Film in the Human Prescription Drug category. It is labeled and distributed by Aquestive Therapeutics. The primary component is Riluzole.
Product ID | 10094-350_2214fe05-3eae-4b7e-b9d9-70c388ae7500 |
NDC | 10094-350 |
Product Type | Human Prescription Drug |
Proprietary Name | EXSERVAN |
Generic Name | Riluzole |
Dosage Form | Film |
Route of Administration | ORAL |
Marketing Start Date | 2019-01-24 |
Marketing Category | NDA / NDA |
Application Number | NDA212640 |
Labeler Name | Aquestive Therapeutics |
Substance Name | RILUZOLE |
Active Ingredient Strength | 50 mg/1 |
Pharm Classes | Benzothiazole [EPC],Benzothiazoles [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2022-12-31 |
Marketing Start Date | 2019-01-24 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA212640 |
Product Type | HUMAN PRESCRIPTION DRUG |
Marketing Start Date | 2019-01-24 |
Ingredient | Strength |
---|---|
RILUZOLE | 50 mg/1 |
SPL SET ID: | 0a4ad0db-ce67-4724-91d2-88258c2cc9f8 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
10094-350 | EXSERVAN | riluzole |
70510-2201 | Exservan | riluzole |
70510-2202 | Exservan | riluzole |
70515-700 | Rilutek | riluzole |
0378-4145 | Riluzole | riluzole |
42291-775 | Riluzole | riluzole |
60505-3285 | RILUZOLE | RILUZOLE |
62756-538 | Riluzole | Riluzole |
64980-191 | Riluzole | riluzole |
67877-286 | Riluzole | Riluzole |
68084-908 | RILUZOLE | RILUZOLE |
68462-381 | riluzole | riluzole |
69076-200 | Riluzole | riluzole |
69076-611 | Riluzole | Riluzole |
70726-0303 | TIGLUTIK | Riluzole |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
EXSERVAN 90792818 not registered Live/Pending |
Aquestive Therapeutics, Inc. 2021-06-24 |
EXSERVAN 90303402 not registered Live/Pending |
AQUESTIVE THERAPEUTICS, INC. 2020-11-06 |
EXSERVAN 87512075 not registered Live/Pending |
AQUESTIVE THERAPEUTICS, INC. 2017-06-30 |